Compare NERV & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NERV | MED |
|---|---|---|
| Founded | 2007 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.4M | 133.7M |
| IPO Year | 2014 | 1996 |
| Metric | NERV | MED |
|---|---|---|
| Price | $3.41 | $12.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $10.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 120.5K | 87.8K |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $41,175,600.00 | ★ $934,842,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.06 | $9.22 |
| 52 Week High | $12.46 | $14.15 |
| Indicator | NERV | MED |
|---|---|---|
| Relative Strength Index (RSI) | 33.97 | 56.70 |
| Support Level | N/A | $12.24 |
| Resistance Level | $4.73 | $13.30 |
| Average True Range (ATR) | 0.28 | 0.32 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 7.98 | 59.34 |
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.